Research Article
Banff 2016 Global Assessment and Quantitative Scoring for T Cell-Mediated Liver Transplant Rejection are Interchangeable
Table 3
Biopsy characteristics and histopathological outcome of the cohort.
| Number of transplant recipients who underwent at least 1 biopsy in 12 months post-transplant | 60 (37%) |
| Total number of biopsies | 90 | Biopsies/patient | Number of patients | 1 | 41 (69%) | 2 | 13 (21%) | 3 | 3 (4.9%) | 4 | 1 (1.6%) | 5 | 2 (3.3%) | Time between LT and biopsy procedure | | Days | Number of biopsies | 1–90 | 54 (60%) | 91–180 | 16 (18%) | 181–365 | 20 (22%) | Histopathological outcome of biopsies | Number of biopsies | T cell-mediated rejection (TCMR) | 64 (71.1%) | Nonspecific changes | 8 (8.9%) | Preservation-reperfusion injury | 4 (4.4%) | Cholestatic hepatitis | 4 (4.4%) | Chronic rejection | 3 (3.3%) | Hepatitis C virus | 3 (3.3%) | Other∗ | 4 (4.4%) |
|
|
∗Steatosis, submassive necrosis, insufficient tissue, suboptimal biopsy.
|